CN Patent

CN101208316B — 制备β-模拟物的方法

Assigned to Boehringer Ingelheim International GmbH · Expires 2012-05-09 · 14y expired

What this patent protects

本发明涉及一种制备式(1)的β-模拟物的方法，其中n代表1或2；R 1 代表氢、卤素、C 1-4 -烷基或O-C 1-4 -烷基；R 2 代表氢、卤素、C 1-4 -烷基或O-C 1-4 -烷基；R 3 代表氢、C 1-4 -烷基、OH、卤素、O-C 1-4 -烷基、O-C 1-4 -亚烷基-COOH、O-C 1-4 -亚烷基-COO-C 1-4 -烷基。

USPTO Abstract

本发明涉及一种制备式(1)的β-模拟物的方法，其中n代表1或2；R 1 代表氢、卤素、C 1-4 -烷基或O-C 1-4 -烷基；R 2 代表氢、卤素、C 1-4 -烷基或O-C 1-4 -烷基；R 3 代表氢、C 1-4 -烷基、OH、卤素、O-C 1-4 -烷基、O-C 1-4 -亚烷基-COOH、O-C 1-4 -亚烷基-COO-C 1-4 -烷基。

Drugs covered by this patent

Patent Metadata

Patent number
CN101208316B
Jurisdiction
CN
Classification
—
Expires
2012-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.